Ortec International said Tuesday (20th June) the European patent office has granted the firm a patent on its Fibrin Microbead technology for isolating certain types of adult stem cells. The technology has previously been granted five U.S. patents.

The Fibrin technology is a proprietary matrix for isolating, expanding and differentiating Mesenchymal-type adult stem cells, a process that could be useful for using the cells to treat patients.

Link


  • European agency opposes patent on embryonic stem cells
  • Stem-Cell Patents to be Reviewed by the Federal Government
  • Australia issues patent on Stem Cell Therapeutics Corp over neural stem cell research
  • U.S. Patents may encourage Novocell to initiate more groundbreaking stem cell research
  • Korean Govt. Offers Support for Stem Cell Research by Prof. Hwang Woo-suk
  • World's first ever stem cell patent is received by Japan University
  • Reliance Life Sciences Files US Patent for Improved Techniques to Harvest Stem Cells from Embryonic and Placental Cord Blood Cells
  • Massachusetts researchers claimed to have created pluripotent stem cells without side effect
  • Artecel & University of Pittsburgh Wins Legal Victory Over Adipose-Derived Stem Cell Patent
  • Sickle Cell Mutation Provides Faster & More Efficient Adult Stem Cell Reprogramming To Embryonic Like Stem Cells